About 9 results found for searched term "84-02-6" (0.056 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M3165 | Prochlorperazine dimaleate | Dopamine Receptor |
| Prochlorperazine dimaleate is a D2 dopamine receptor antagonist. | ||
| M3275 | Irbesartan | Angiotensin Receptor |
| SR-47436; BMS-186295 | ||
| Irbesartan (SR-47436, BMS-186295) is a highly potent and specific angiotensin II type 1 (AT1) receptor antagonist with IC50 of 1.3 nM. | ||
| M1554 | N-Desmethyl Imatinib | Metabolite/Endogenous Metabolite |
| N-Desmethyl Imatinib; Norimatinib | ||
| N-Desmethyl Imatinib | ||
| M5900 | Prochlorperazine dimaleate salt | Dopamine Receptor |
| Prochlorperazin, Compazine, Capazine, Stemetil | ||
| Prochlorperazine dimaleate is a dopamine (D2) receptor antagonist. | ||
| M8325 | DR2313 | Others |
| DR2313 is a PARP-1; PARP-2 inhibitor (Ki = 0. | ||
| M25256 | Lexatumumab | Apoptosis |
| HGS-ETR 2 ETR2-ST01 Anti-Human ERBB3 Recombinant Antibody | ||
| Lexatumumab (HGS-ETR 2) is a human agonistic TRAIL receptor 2 (TRAIL-R2, DR5, APO-2) IgG4κ type monoclonal antibody. Lexatumumab induces apoptosis in malignant mesothelioma. Lexatumumab can be used for malignant pleural mesothelioma (MPM) research. | ||
| M28944 | FF-10502 | Nucleoside Antimetabolite/Analog |
| FF-10502, a structural analog of Gemcitabine, is a pyrimidine nucleoside antimetabolite. FF-10502 inhibits DNA polymerase α and β. FF-10502 shows beneficial anticancer activity via a mechanism of action on dormant cells. | ||
| M43477 | BTK-IN-27 | BTK |
| BTK-IN-27 is a BTK inhibitor (IC50: 0.2 nM). | ||
| M52947 | UFP-101 | Opioid Receptor |
| UFP-101 is a potent, selective, and competitive antagonist of the NOP receptor, with a pKi of 10.24. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.
